LOGO
LOGO

breaking news

  • Alnylam To Expand Massachusetts Manufacturing Facility With $250 Million Investment December 17, 2025 08:41 ET

    Alnylam Pharmaceuticals (ALNY) on Wednesday said it plans to expand its manufacturing facility in Norton, Massachusetts, with an investment of about $250 million. The expansion is intended to support a fully dedicated, siRNA (small interfering RNA) enzymatic-ligation manufacturing facility. As part...

  • Bombardier Is On Track To Reach Net Leverage Ratio Target Following $500 Mln Debt Redemption Notice December 17, 2025 08:35 ET

    Bombardier Inc. (BDRXF.PK), Wednesday announced that it is on track to reach its previously stated net leverage ratio target of 2.0-2.5x. This comes as the company will reduce its long-term debt by $5.5 billion following the previously announced $500 million debt redemption notice, resulting in an...

  • Jabil Lifts Annual Outlook Above View, Expects Q2 Results In Line With Analysts' Forecast; Stock Up December 17, 2025 08:35 ET

    Jabil Inc. (JBL), an engineering, manufacturing, and supply chain services company, on Wednesday revised up its annual guidance, better than analysts' expectations, citing a robust demand. For fiscal 2026, the company now expects core earnings of $11.55 per share, higher than the earlier guidance...

  • Steel Dynamics Issues Q4 Earnings Guidance December 17, 2025 08:22 ET

    Steel Dynamics, Inc. (STLD) said it expects fourth quarter earnings in the range of $1.65 to $1.69 per share. Comparatively, prior year fourth quarter earnings were $1.36 per share. The company currently plans to release its fourth quarter earnings on January 26, 2026. The company noted that it has...

  • Cytokinetics Wins China Approval For Myqorzo In Obstructive Hypertrophic Cardiomyopathy December 17, 2025 08:15 ET

    Cytokinetics, Incorporated (CYTK) said on Wednesday that China's National Medical Products Administration has approved Myqorzo for the treatment of adults with obstructive hypertrophic cardiomyopathy. Under its license and collaboration agreement, Sanofi holds exclusive rights to develop and commercialize...

  • Beneficient Appoints Peter Cangany As Chairman Of The Board December 17, 2025 08:07 ET

    Beneficient (BENF), a Dallas-based, technology-driven financial services company, on Wednesday announced that it has appointed Peter Cangany as Chairman of the Board, effective December 15. Cangany brings decades of experience and has retired as a partner of Ernst & Young LLP. Cangany currently...

  • Blackstone Teams Up With Phoenix Financial To Expand Credit Strategies December 17, 2025 08:03 ET

    Blackstone Inc. (BX), Wednesday announced enters into an agreement with Phoenix Financial, an asset management and insurance company, to collaborate across a range of credit strategies, including corporate, real estate and asset-based credit. As per the deal, Phoenix will invest up to $5 billion across...

  • Nucor Forecasts Sequential Decline In Q4 Earnings December 17, 2025 07:58 ET

    Nucor Corporation (NUE) on Wednesday issued earnings guidance for the fourth quarter ending December 31, 2025. The steelmaker expects fourth-quarter earnings in the range of $1.65 to $1.75 per share, down from $2.63 per share reported in the third quarter, but higher than $1.22 per share recorded...

  • ABM Industries Turns To Q4 Profit, Lifts Dividend; Sees Growth In FY26 December 17, 2025 07:55 ET

    Facility management company ABM Industries, Inc. (ABM) reported Wednesday a profit in its fourth quarter, compared to prior year's loss, amid higher revenues. The company also announced higher dividend, and issued fiscal 2026 outlook, expecting a growth. In pre-market activity on the NYSE, the shares...

  • ABM Industries To Buy WGNSTAR For Around $275 Mln In Cash December 17, 2025 07:51 ET

    ABM Industries Inc.(ABM), a provider of integrated facility, infrastructure, and technical solutions, on Wednesday announced a deal to acquire WGNSTAR, a provider of managed workforce solutions and equipment support services, for around $275 million in cash. The transaction, to be closed in the ABM's...

  • General Mills Q2 Earnings Decline; Reaffirms Outlook December 17, 2025 07:42 ET

    General Mills, Inc. (GIS), a food company, on Wednesday reported its net income decreased in the second quarter compared with the previous year. For the second quarter, net income decreased 48 percent to $413 million from $795.7 million in the previous year. Earnings per share were $0.78 versus...

  • Traws' Ratutrelvir Shows Activity In PAXLOVID-Ineligible COVID-19 Patients; Final Data Due In Jan. December 17, 2025 07:37 ET

    Traws Pharma, Inc. (TRAW) reported positive interim data from its ongoing Phase 2 study of Ratutrelvir, demonstrating antiviral activity in patients with mild-to-moderate COVID-19 who are ineligible for Paxlovid, Pfizer's oral antiviral.

  • Netflix Is Right Home For Warner Bros, Says Co-CEO December 17, 2025 07:34 ET

    Netflix (NFLX) welcomed the recommendation from the Warner Bros. Discovery (WBD) Board for stockholders to reject the unsolicited offer from Paramount Skydance (PSKY), launched on December 8, 2025. Ted Sarandos and Greg Peters sent letter to Warner Bros. Discovery stockholders, and said they believe...

  • 4D Molecular Therapeutics Reports Positive Interim Phase 1 Data For 4D-710 In Cystic Fibrosis December 17, 2025 07:32 ET

    4D Molecular Therapeutics Inc. (FDMT) on Wednesday reported positive interim results from its Phase 1 AEROW study evaluating 4D-710, the company's gene therapy candidate for the treatment of cystic fibrosis lung disease. The study enrolled patients with cystic fibrosis who were ineligible for or intolerant...

  • Protalix, Secarna Partner To Develop ASO Treatments For Rare Renal Conditions December 17, 2025 07:24 ET

    Wednesday, Protalix BioTherapeutics, Inc. (PLX) announced a collaboration and option agreement with Secarna Pharmaceuticals GmbH & Co. KG, a Germany-based biopharmaceutical company, to discover novel antisense oligonucleotide or ASO therapies against multiple targets for rare renal indications. Under...

Global Economics Weekly Update - Dec 08 to Dec 12, 2025

December 12, 2025 15:14 ET
Central bank decisions dominated the economic news flow this week led by the Federal Reserve. Trade data from the U.S. also gained attention. The Canadian and Swiss central banks also announced their interest rate decisions. Inflation data from China was in focus as the country released the latest consumer price and producer price data.